Growth Stocks Investors Love
Stocks that are expected to significantly grow their profitability in the future can add meaningful upside to your portfolio. Bay Banks of Virginia and Broadcom are examples of many high-growth stocks that the market believe will be upcoming outperformers. If your holdings could benefit from diversification towards growth stocks, whether it be in reputable tech stocks or green small-caps, take a look at my list of stocks with a bright future ahead.
Bay Banks of Virginia, Inc. (OTCPK:BAYK)
Bay Banks of Virginia, Inc. operates as the bank holding company for Bank of Lancaster that provides various banking products and services to businesses, professionals, and consumers in Virginia. Formed in 1930, and now run by Randal Greene, the company now has 112 employees and with the company’s market capitalisation at USD $139.86M, we can put it in the small-cap stocks category.
Want to know more about BAYK? Have a browse through its key fundamentals here.
Broadcom Limited (NASDAQ:AVGO)
Broadcom Limited designs, develops, and supplies a range of semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. Formed in 2005, and run by CEO Hock Tan, the company now has 14,000 employees and with the market cap of USD $103.04B, it falls under the large-cap group.
AVGO is expected to deliver an extremely high earnings growth over the next couple of years of 42.80%, driven by a positive double-digit revenue growth of 26.10% and cost-cutting initiatives. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 34.65%. AVGO ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Should you add AVGO to your portfolio? Take a look at its other fundamentals here.
TG Therapeutics, Inc. (NASDAQ:TGTX)
TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. The company employs 69 people and with the company’s market cap sitting at USD $798.37M, it falls under the small-cap group.
TGTX’s projected future profit growth is a robust 30.98%, with an underlying triple-digit growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. TGTX ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Could this stock be your next pick? Have a browse through its key fundamentals here.
For more financially robust companies with high growth potential to enhance your portfolio, use our free platform to explore our interactive list of these stocks.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
